Phocas Financial Corp’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-151,951
Closed -$8.88M 67
2019
Q4
$9.04M Sell
151,951
-38,100
-20% -$2.05M 1.09% 24
2019
Q3
$10.1M Sell
190,051
-691
-0.4% -$35.5K 1.08% 23
2019
Q2
$9.74M Buy
+190,742
New +$8.88M 1.04% 28
2019
Q1
Sell
-212,684
Closed -$10.3M 28
2018
Q4
$8.37M Buy
212,684
+92,521
+77% +$4.3M 0.93% 38
2018
Q3
$6.19M Buy
+120,163
New +$5.88M 0.54% 80
2018
Q2
Hold
0
89
2018
Q1
Hold
0
105

Other funds holding SYNH

Phocas Financial Corp's SYNH Position: Q1 2020 in Review

Phocas Financial Corp sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2020, closing a stake of 151,951 shares — an estimated $8.88M sold.

Phocas Financial Corp first reported a position in SYNH in Q3 2018 and held it in 5 quarters. The position peaked at $10.1M in Q3 2019. 260 funds tracked by Wall St. Rank hold SYNH as of Q1 2020.

  • Phocas Financial Corp reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2020 after selling out during the quarter.
  • Phocas Financial Corp sold 151,951 Syneos Health, Inc. Class A Common Stock shares in Q1 2020, an estimated $8.88M.
  • Phocas Financial Corp first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2018 and held it in 5 quarters.
  • Phocas Financial Corp's Syneos Health, Inc. Class A Common Stock position peaked at $10.1M in Q3 2019.
  • 260 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2020.

Based on Phocas Financial Corp's 13F filing for Q1 2020, filed 15 May 2020.